Kiren Rijiju,Union Minister for Earth Sciences National Disaster...
Category:
Health
Latest
Extreme heat to scorch India during election period, says IMD
Gujarat, Maharashtra, north Karnataka, Odisha, west Madhya Pradesh...
Group of oncologists launch free-of-cost second opinion helpline number for cancer patients
Sharing the reason behind starting this helpline number, he said...
Govt determined to vaccinate everyone by December this year: Union Minister Kishan Reddy
”We want to reach out to the last person to be vaccinated in the country, in the most remotest part by December this year. It is also a matter of great pride that India was one of the two countries which invented a vaccine for COVID, besides USA, this raised the stature of Indian scientists and the country in the world,” the release quoted Kishan Reddy as saying.
”As many as 153 countries have sought our vaccines and some even paid the respective companies advance amount, but the government placed an embargo on export till people in our country are vaccinated,” he said.
Study suggests Delta does not cause more severe childhood Covid
The paper by the Centers for Disease Control and Prevention also found that between June 20 and July 31, 2021, unvaccinated adolescents were more than 10 times more likely to be hospitalized than those who were vaccinated.
One in every two families paid over Rs 750 for COVID antibody test in India: Survey
According to the survey, 29 per cent of the respondents said they paid Rs 1,000 or more during their COVID antibody test. Further, 21 per cent said they paid between Rs 750-1000 and 14 per cent said they paid between Rs 500-750.
While, 24 per cent said they paid Rs 250-500 and 7 per cent said they paid less than Rs 250. 5 per cent respondents did not say anything. “On an aggregate basis, 50 per cent of citizens who got a COVID antibody test done paid over Rs 750 for it,” said LocalCircles release.
FSSAI asks e-tailers to delist non-dairy products claiming as dairy items
”Since a lot of such products are sold through e-commerce Food Business Operators (FBOs), FSSAI has instructed all e-commerce platforms to delist such products, which are reported to be in contravention to the regulatory provisions related to the application of dairy ‘terms’ from their online platforms, immediately,” it said.
The FSSAI has further directed that no such defaulting products listed on the online platforms are allowed for sale in the future as well.
Govt revises NLEM: Slashes prices of 39 commonly used medicines
The commonly used drugs, which were brought under the price cap includes Teneligliptin — an anti diabetes drug, popular anti-TB drugs, Ivermectin — used in Covid treatment, Rotavirus vaccine, among others.
India in need of 4.3 million more nurses by 2024 to meet WHO norms
With 1.7 nurses per 1,000 population, India falls short of the WHO recommended rate of 3 nurses per 1,000 population, they said, noting that the country is in need of 4.3 million more nurses by 2024 to meet WHO norms.
Covid-19 jabs effective at reducing severe illness, hospitalisation: Lancet
They found that of more than 1.2 million adults who received at least one dose of either the Pfizer-BioNTech, Oxford-AstraZeneca, or Moderna vaccine, fewer than 0.5 per cent reported a breakthrough infection over 14 days after their first dose.
People most vulnerable to a breakthrough infection after their first vaccine dose included frail older adults, 60 years and older, and those living with underlying conditions such as obesity, heart disease, kidney disease, and lung disease, they said.
Improve support for rising numbers living with dementia, urges WHO
The disability associated with dementia is a key driver of costs related to the condition. In 2019, the global price tag was estimated at $1.3 trillion – a number that is projected to rise to $1.7 trillion by 2030, or $2.8 trillion if care costs are included.
After dropping below one, Covid R-value rises sharply to 1.17 in second half of August
When the second wave swept through the country between March to May, the R-value was 1.37 (between March 9 to April 21). From May 15-June 26, the R-value stood at 0.78. However, it slowly started increasing — it was 0.88 from June 20-July 7, 0.95 from July 3-22, 0.96 from July 24-27. It breached the value of 1.03 for the first time after the second wave during July 27-31. However, since then it has slowly started to decline.
Biological E gets nod for phase 2/3 clinical trial on children, adolescents
So far indigenously developed Zydus Cadila’s needle-free COVID-19 vaccine ZyCoV-D has received emergency use authorisation from the drug regulator, making it the first vaccine to be administered in the age group of 12-18 years in the country.